2007
DOI: 10.1016/j.jamcollsurg.2007.02.027
|View full text |Cite
|
Sign up to set email alerts
|

Correlation of TLK1B in Elevation and Recurrence in Doxorubicin-Treated Breast Cancer Patients with High eIF4E Overexpression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 21 publications
(15 citation statements)
references
References 23 publications
0
15
0
Order By: Relevance
“…43 TLKs Are Targets for Therapeutic Intervention. The TLKs are becoming the center of much attention for their role in DSB repair 4,19,44 and their potential contribution to cancers refractory to XRT or RMT, including cholangiocarcinoma, 45 BCA, 8 and CaP. 11 Note, however, that probably most technologies directed at globally reducing the expression of TLKs are unlikely to result in effective and safe therapies.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…43 TLKs Are Targets for Therapeutic Intervention. The TLKs are becoming the center of much attention for their role in DSB repair 4,19,44 and their potential contribution to cancers refractory to XRT or RMT, including cholangiocarcinoma, 45 BCA, 8 and CaP. 11 Note, however, that probably most technologies directed at globally reducing the expression of TLKs are unlikely to result in effective and safe therapies.…”
Section: Discussionmentioning
confidence: 99%
“…The past few years have witnessed significant advances in understanding the roles of TLKs in the DDR 7 and in DSB repair 4 as well as their clinical relevance. In BCA, elevated expression of the TLK1B splice form is found in approximately 30% of the patients and often corresponds to poor response to XRT and doxorubicin (doxo), 8 presumably due to efficient DSB repair in the tumor cells. We postulated that its expression could serve as a marker for prognosis as well as a target for therapeutic intervention.…”
Section: Introductionmentioning
confidence: 99%
“…The past few years have witnessed significant advances in understanding the roles of TLKs in the DDR [66] and in direct repair of DSBs [9], as well as their clinical relevance. In BCA, elevated expression of the TLK1B splice form is found in ~30% of the patients [67] and often corresponds to poor response to XRT [68] and doxorubicin [67], presumably due to efficient repair of DSBs in the tumor cells. We postulated that its expression could serve as a marker for prognosis as well as a target for therapeutic intervention.…”
Section: Tlks In Man As Guardians Of Genome Stability and Their mentioning
confidence: 99%
“…The suspected mechanism of action is chromatin remodeling caused by histone H3 phosphorylation [16]. This is important because doxorubicin, a commonly used therapy for breast cancer, functions by damaging DNA via double-stranded breaks [17]. In breast cancer patients, Byrnes and colleagues reported that a high TLK1B overexpression not only correlates with eIF4E overexpression, but also is associated with an increased risk for recurrence in patients receiving doxorubicin-based therapy [17].…”
Section: Introductionmentioning
confidence: 99%